Ratings by Cantor Fitzgerald (William Tanner)
Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/15/2021 | Novavax | NVAX | Maintain | Overweight (N/A) |
|
Details | ||
7/7/2020 | Novavax | NVAX | Maintain | Overweight (N/A) |
|
Details | ||
5/13/2020 | Novavax | NVAX | Maintain | Overweight (N/A) |
|
Details | ||
9/27/2018 | Novavax | NVAX | Maintain | Neutral (N/A) |
|
Details | ||
9/26/2018 | Evofem Biosciences Inc | EVFM | New Coverage | Overweight (N/A) |
4.02 (4.98) |
23.88% | Details | |
9/12/2018 | Vital Therapies | VTL | Downgrade | Neutral (Overweight) |
6.30 (0.83) |
-86.83% | Details | |
8/21/2018 | Vital Therapies | VTL | New Coverage | Overweight (N/A) |
9.00 (6.30) |
-30% | Details |